
PTSF59 – Psychedelics and Bipolar, with Benjamin Mudge
Psychedelics Today
00:00
The Cultural Taboo About the Contraindication Status of Psychedelics
Bipolar disorder should be 'a shame free practical instruction manual that is empowering' But at the moment it comes with a contract with psychiatric profession and pharmaceutical industry. In like the US and UK, they're spent approximately $1 billion per year treating attempting to treat bipolar disorder but failing dismally in doing so. If 1% of that was redistributed into a psychedelic trial then they could make a difference, for example.
Transcript
Play full episode